Dr. Lacroix participated in the launch of the first GeneChem Fund in 1997. He has so far been on the Board of Directors of fifteen companies. Prior to becoming a venture capitalist, Dr. Lacroix, a co-founder of BioChem Pharma Inc. (acquired by Shire Pharmaceuticals Group in 2001), acted as a Director for Technology Transfer at BioChem Pharma. From 1986 to 1995, he held a number of positions with BioChem ImmunoSystems, Inc., including Director, Research and Development and Director, Quality Control. Between 1981 and 1986, Dr. Lacroix was a Professor in the Department of Virology at Institut Armand-Frappier. Dr. Lacroix received a B.Sc. and a M.Sc. in Biochemistry from Université de Montréal and a Ph.D. from the University of Toronto. Dr. Lacroix has authored 33 scientific publications and holds eight issued patents.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
AgeChem Venture Fund | General Partner | — | — | Detail |